Clinical Spectrum of Primary Hyperparathyroidism

Reviews in Endocrine and Metabolic Disorders

Volumn 1, Issue 4, 2000, Pages 237-245

  Bilezikian, John P ^a   Silverberg, Shonni J ^a  

^a Columbia University ^*  (United States)

Author keywords

Hyperparathyroidism; Nephrolithiasis; Parathyroid adenoma; Primary hyperparathyroidism

Indexed keywords

ANIMAL; DISEASE COURSE; HUMAN; HYPERPARATHYROIDISM; PATHOLOGY; REVIEW;

ANIMALS; DISEASE PROGRESSION; HUMANS; HYPERPARATHYROIDISM;

EID: 0034332484     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026508829397     Document Type: Article

References (43)

1. Cope O. The story of hyperparathyroidism at the massachusetts general hospital. N Engl J Med 1966;21(1): 174-1182.
2. Albright F, Aub JC, Bauer W. Hyperparathyroidism common and polymorphic condition as illustrated by seventeen proved cases from one clinic. J Am Med Assoc 1934;102:1276-1287.
3. Keating FR Jr, Cook EN. Recognition of primary hyperparathyroidism: analysis of 24 cases. J Ain Med Assoc 1945;129:994-1002.
4. Heath H III, Hodgson SF, Kennedy M. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980;302:189-193.
5. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980;1:1317-1320.
6. Stenstrom G, Heedman P. Clinical findings in patients with hypercalcemia: a final investigation based on biochemical screening. Acta Med Scand 1974;195:473-477.
7. Melton LJ III. Epidemiology of primary hyperparathyroidism. J Bone Mineral Res 1991;6(Suppl 2):S25-S30.
8. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997;126:433-440.
9. Cohen J, Gierlowski TC, Schneider AB. A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA 1990;264:581-584.
10. Bondeson AG, Bondeson L, Thompson NW. Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence?. Surgery 1989;106:1025-1027.
11. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Mineral Res 1991;6(Suppl I):585-589.
12. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. The natural history of treated and untreated asymptomatic primary hyperparathyroidism: a ten year prospective study. N Engl J Med 1999;341:1249-1255.
13. Silverberg SJ, Shane E, DeLaCruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Mineral Res 1989;4:283-291.
14. Turken SA, Cafferty M, Silverberg SJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 1989;87:553-557.
15. Parisien MV, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990;70:930-938.
16. M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel, Recker R, Bilezikian JP, Lindsay R, Dempster DW. Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women. J Bone Min Res 1995;10:1393-1399.
17. Dempster DW, Parisien M, Silverberg SJ, Liang X-G, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 1999;84:1562-1566.
18. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:4007-4012.
19. Miller PD, Bonnick SL. Clinical applications of bone densitometry. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edition (Favus MJ), Philadelphia: Lippincott Williams & Co, 1999;152-159.
20. Dauphine RT, Riggs BL, Scholz DA. Back pain and vertebral crush fractures: an unrecognized mode of presentation for primary hyperparathyroidism. Ann Intern Med 1975;83:365-367.
21. RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988;109:959-962.
22. LJ III, Atkinson EJ, O'Fallon WM, Heath H III. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992;152:2269-2273.
23. Kleerekoper M, Peterson E, Nelson D, et al. Identification of women at risk for developing postmenopausal osteoporosis with vertebral compression fractures: role of history and single photon absorptiometry. Bone Mineral 1989;7:171-186.
24. Johnson BE, Lucasey B, Robinson RG, Lukert BP. Contributing diagnoses in osteoporosis. Arch Intern Med 1989;149:1069-1072.
25. Khosla S, Melton LJ III, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Min Res 1999;14:1700-1707.
26. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bilezikian JP. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990;89:327-334.
27. Albright F, Reifenstein EC. The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins, 1948.
28. Fitzpatrick LA, Bilezikian JP. Acute primary hyperparathyroidism. Am J Med 1987;82:275-282.
29. Locker FG, Silverberg SJ, Bilezikian JP. Optimal calcium intake in primary hyperparathyroidism. Am J Med 1997;102:543-550.
30. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. Vitamin D Deficiency in primary hyperparathyroidism. Am J Med 1999;107:561-567.
31. Deftos LJ. Markers of bone turnover in primary hyperparathyroidism. In: Bilezikian JP (ed.): The Parathyroids: Basic and Clinical Concepts. New York: Raven Press, 1994;485-492.
32. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezkian JP. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74:481-486.
33. LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: Clinical and biochemical features. Medicine 1974;53:127-146.
34. Parisien M, Mellish RWE, Silverberg SJ, et al. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Mineral Res 1992;7:913-920.
35. Deaconson TF, Wilson SD, Lemann J. The effect of parathyroidectomy on the recurrence of nephrolithiasis. Surgery 215:241-251.
36. Palmer M, Adami H-O, Bergstrom R, Akerstroon G, Ljunghall, S. Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 1987; 102:1-7
37. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton LJ III. Survival after the diagnosis of hyperparathyroidism: a population based study. Am J Med 1998;104:115-122.
38. Harinarayan DV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol 1995;43:351-358.
39. Luong KVQ, Nguyen LTH. Co-existing hyperthyroidism and hyperparathyroidism with vitamin D deficient osteomalacia in a Vietnamese immigrant. Endocr Practice 1996;2:250-254.
40. XW, Xing XP, Liu SQ, Zhan ZW. The diagnosis of primary hyperparathyroidism- analysis of 134 cases. Acta Acad Med Sinicae 1994;16:13.
41. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: New York and Beijing (A Tale of Two Cities). Int'l J Fertil and Women's Health 2000;45:158-165 (in press), 2000;
42. Patron P, Gardin J-P, Paillard M. Renal mass and reserve of vitamin D. Determinants in primary hyperparathyroidism. Kidney Int 1987;31:1174-1180.
43. Lumb GA, Stanbury SW. Parathyroid function in vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974;54:833-839.